Covered recipient · General Payments record
DINA KHALAF
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2025
$1,186.71
- Reported across 15 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $986.73 | 13 |
| Education | $199.98 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Geron Corporation | $259.06 | 4 |
| Astellas Pharma US Inc | $204.67 | 3 |
| Kite Pharma, Inc. | $170.64 | 2 |
| Celgene Corporation | $146.89 | 1 |
| Stemline Therapeutics Inc. | $122.56 | 1 |
| Tempus AI, Inc | $107.55 | 1 |
| E.R. Squibb & Sons, L.L.C. | $97.06 | 1 |
| TAIHO ONCOLOGY, INC. | $50.00 | 1 |
| Adaptive Biotechnologies Corporation | $28.28 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $1,186.71 | 15 |
Payment records · PY2025 (15)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation | $28.28 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254936054 | CMS |
| Astellas Pharma US Inc | $4.69 | 09/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238678555 | CMS |
| Astellas Pharma US Inc | $99.99 | 11/14/2025 | Education | Undisputed | 06/30/2026 | 1238563052 | CMS |
| Astellas Pharma US Inc | $99.99 | 11/14/2025 | Education | Undisputed | 06/30/2026 | 1238586240 | CMS |
| Celgene Corporation | $146.89 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184484036 | CMS |
| E.R. Squibb & Sons, L.L.C. | $97.06 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184484020 | CMS |
| Geron Corporation | $27.47 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238889884 | CMS |
| Geron Corporation | $109.23 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238889886 | CMS |
| Geron Corporation | $52.28 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238889888 | CMS |
| Geron Corporation | $70.08 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238889890 | CMS |
| Kite Pharma, Inc. | $68.21 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212083439 | CMS |
| Kite Pharma, Inc. | $102.43 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212083441 | CMS |
| Stemline Therapeutics Inc. | $122.56 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244091944 | CMS |
| TAIHO ONCOLOGY, INC. | $50.00 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211414156 | CMS |
| Tempus AI, Inc | $107.55 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250347619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.